POLYOMAVIRUS-ASSOCIATED NEPHROPATHY

This adverse event was reported 2345 times

POLYOMAVIRUS-ASSOCIATED NEPHROPATHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE 1 0.0714
1 HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN 30 0.0617
2 BASILIXIMAB 395 0.0331
3 CIDOFOVIR ANHYDROUS 45 0.0311
4 BRINCIDOFOVIR 3 0.0216
5 EVEROLIMUS TABLETS 308 0.0180
6 ANTI-THYMOCYTE GLOBULIN (RABBIT) 142 0.0175
7 SIROLIMUS 202 0.0148
8 TACROLIMUS OINTMENT 0.1% 1736 0.0136
9 TACROLIMUS EXTENDED-RELEASE CAPSULES 1736 0.0136
See all drugs enriched for association with POLYOMAVIRUS-ASSOCIATED NEPHROPATHY